Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Forte Biosciences, Inc. (FBRX) had Normalized Income after Taxes of $-11.25M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-11.25M |
|
-- |
|
-- |
|
$11.58M |
|
$-11.58M |
|
$0.33M |
|
$-11.25M |
|
$-11.25M |
|
$-11.25M |
|
$-11.25M |
|
$-11.25M |
|
|
Normalized Income after Taxes |
$-11.25M |
$-11.58M |
|
$-11.80M |
|
11.74M |
|
11.74M |
|
$-0.96 |
|
$-0.96 |
|
| Balance Sheet Financials | |
$107.62M |
|
$0.11M |
|
$0.17M |
|
$107.78M |
|
$9.17M |
|
-- |
|
-- |
|
$9.17M |
|
$98.61M |
|
$98.61M |
|
$98.61M |
|
12.28M |
|
| Cash Flow Statement Financials | |
$-20.42M |
|
$36.29M |
|
$68.03M |
|
$22.24M |
|
$106.14M |
|
$83.90M |
|
$3.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.74 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.41% |
|
-11.41% |
|
-10.44% |
|
-11.41% |
|
$8.03 |
|
$-1.74 |
|
$-1.74 |
|